Si cantik vitiligo by Harian Metro

Get full text

Vitiligo: symptoms, pathogenesis and treatment by Ghafourian, E., Ghafourian, Sobhan, Sadeghifard, Nourkhoda, Mohebi, Reza, Shokoohini, Y., Nezamoleslami, S., Hamat, Rukman Awang

“…Vitiligo is an acquired cutaneous disorder of pigmentation, with an incidence of 0.5% to 2% worldwide. …”

Woman with vitiligo determined to break stereotypes by Tan, Nurhafizah

Get full text

Woman with vitiligo determined to break beauty stereotypes by The Borneo Post Sarawak

Get full text

Woman with vitiligo determined to break beauty stereotypes by New Sarawak Tribune

Get full text

Vitiligo patient uses modelling side hustle to raise awareness by Daily Express

Get full text

Objective assessment of vitiligo with a computerised digital imaging analysis system by Shamsudin, Norashikin, Hussein, Suraiya, Nugroho, Hermawan, Ahmad Fadzil, Mohd Hani

“…An objective tool to quantify treatment response in vitiligo is currently lacking. This study aimed to objectively evaluate the treatment response in vitiligo by using a computerised digital imaging analysis system (C-DIAS) and to compare it with the physician's global assessment (PGA). …”
Get full text

Role of herbal medicines in vitiligo treatment - current status and future perspectives by Narayanaswamy, Radhakrishnan, Ismail, Intan Safinar

“…Vitiligo is a depigmentation disorder with complex causes. …”
Get full text

Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas by Nugroho, Hermawan, Mohd Hani, Ahmad Fadzil, Shamsudin, Norashikin, Hussein, Suraiya Hani

“…Background: Vitiligo is a cutaneous pigmentary disorder characterized by depigmented macules and patches that result from loss of epidermal melanocytes. …”
Get full text

Antinuclear antibodies in non-systemic autoimmune rheumatic disease dermatological conditions by Mahayidin, Hasni, Bakrin, Ikmal Hisyam

“…This review summarises the available studies on ANA IFA in non-SARD dermatological conditions which include atopic dermatitis (AD), psoriasis, vitiligo and autoimmune bullous diseases. It aims to determine the prevalence of ANA, the commonly reported ANA titres and patterns, as well as any clinical associations between ANA and non-SARD dermatological conditions.…”